biot: Smallpox
DC Home Mayor Fenty DC Guide Residents Business Visitors DC Government Kids

Health Emergency Preparedness

HEPRA HOME
PREPAREDNESS
HEALTH CARE
  RESOURCES

EMERGING
  INFECTIOUS
  DISEASES

ONLINE SERVICE
REQUESTS

About Bioterrorism
How To Reach Us
Ask The Director
FOIA Requests
News Room
Sitemap
EHMSA Online
  Volunteer Form

Bioterrorism Resources
Children & Disasters
DC Metro Health
  Facilities

Disaster Preparedness
Fact Sheets and FAQs
Homeland Security
  Advisory System

In Case of Emergency
Biological and Chemical
  Agents

Diagnosis and Treatment
Emergency Information
SNS Program
Other Resources
SARS
Bird Flu
Journal
Pandemic Flu

Smallpox

All suspect cases of smallpox must be reported immediatly to the Department of Health, (202) 442-5999 or by calling 911.

Epidemiology:

  • Highly infectious after aerosolization
  • Person-to-person transmission can occur via droplet nuclei or aerosols expelled from the oropharynx and by direct contact
  • Contaminated clothing or bed linens can also spread the virus
  • About 30% of susceptible contacts will become infected

Clinical:

  • Incubation period is 12-14 days (ranges 7-17 days)
  • Characteristic rash appears 2-3 days after nonspecific, flu-like prodrome (fever and headache)
  • Maculopapular rash begins on mucosa of mouth and pharynx, face, hands, forearms and spreads to legs and centrally to trunk; lesions are more predominant on the face and extremities than on the trunk.
  • Lesions progress synchronously on any given part of the body from macules to papules to vesicles to pustules to crusty scabs

Laboratory Diagnosis:

  • Mask and gloves should be worn by the person obtaining the specimen, preferably a person who has been recently vaccinated
  • Vesicular fluid is obtained by opening lesions with the blunt edge of a scalpel, harvesting fluid with a cotton swab; scabs can be removed by forceps. Swabs and scabs should be placed in a vacutainer, sealed with tape, and placed in a second, durable, watertight container
  • Laboratory specimens must be handled in a Biosafety Level 4 facility (e.g. CDC) and will be evaluated with electron microscopy and cell culture

Patient Isolation:

  • Strict isolation in negative pressure room (high efficiency particulate air filtration ideal) from onset of rash until all scabs separate
  • Laundry and waste should be autoclaved before being laundered or incinerated

Treatment:

  • Supportive care is the mainstay of therapy
  • In-vitro antiviral activity against poxviruses has been shown with adefovir, cidofovir, dipivoxil, and ribavirin. (Animal studies suggest that cidofovir may be most effective).

Prophylaxis:

  • Smallpox vaccine would be required for all persons exposed at the time of the bioterrorist attack or anyone with close personal contact with a smallpox case
  • Vaccine is most effective if given before of within 3 days of exposure
  • Ideally, all exposed persons should be placed in strict quarantine for 17 days after last contact with a smallpox case